CalciMedica, Inc.
CALC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534133
No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding CalciMedica, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 25 | 25 | 0 |
| Shares | 10.7M | 10.8M | +84.2K (+0.8%) |
| Value | $11.7M | $10.2M | −$1.53M (−13.0%) |
New holders (3)
Institutions that held CalciMedica, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 11,455 | $11.0K | 0.00% |
| BNP Paribas Arbitrage, SA | 114 | $107 | 0.00% |
| JPMorgan Chase & Co | 7 | $0 | 0.00% |
Sold out (3)
Institutions that held CalciMedica, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Two Sigma Investments, LP | 17,218 | $19.0K |
| Levin Capital Strategies, L.P. | 15,000 | $16.0K |
| FMR LLC | 800 | $1.00K |